c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus (Q37256684)

19 August 2017

c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus (English)

1 reference

19 August 2017

1 reference

Hardwick RH

1

1 reference

19 August 2017

Shepherd NA

2

1 reference

19 August 2017

Moorghen M

3

1 reference

19 August 2017

Newcomb PV

4

1 reference

19 August 2017

Alderson D

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 February 1995

1 reference

Journal of Clinical Pathology

19 August 2017

1 reference

19 August 2017

48

1 reference

19 August 2017

2

1 reference

19 August 2017

129-132

1 reference

Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

The subcellular localization of the neu protein in human normal and neoplastic cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

The neoplastic potential of columnar-lined (Barrett's) esophagus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Identification of heregulin, a specific activator of p185erbB2

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice?

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Barrett's esophagus: development of dysplasia and adenocarcinoma

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Oncogenic potential of erbB-2 in human mammary epithelial cells

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502378

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity

3 September 2018

1 reference

12 December 2020

Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction

1 reference

12 December 2020

Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon

1 reference

12 December 2020

NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue

1 reference

12 December 2020

Expression of C-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for C-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma

1 reference

12 December 2020

An immunohistochemical study of c-erbB-2 protein in gastric carcinomas and lymph-node metastases: is the c-erbB-2 protein really a prognostic indicator?

1 reference

12 December 2020

Immunocytochemical localization of c-erbB-2 protein in transitional cell carcinoma of the urinary bladder

1 reference

12 December 2020

Amplification and over-expression of theEGFR anderbB-2 genes in human esophageal adenocarcinomas

1 reference

12 December 2020

p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study

1 reference

12 December 2020

Adenocarcinoma and Barrett's esophagus. An overrated risk?

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.48.2.129

1 reference

19 August 2017

1 reference

19 August 2017

1 reference